This allows you to see at a glance whether you have taken your dose for the day, reducing uncertainty and the risk of accidental double-dosing
Another obesity drug under investigation by Lilly, retatrutide, demonstrates even greater weight loss but is still in mid-stage clinical trials
Kidney problems, including acute kidney injury, have also been reported, potentially requiring medical intervention
This has been attributed primarily to increased gastrointestinal oxalate absorption, leading to greater urinary oxalate excretion, but also to lower citrate excretion and lower urine pH
Unspecified indications for the use of tirzepatide were recorded in 57.3% of cases, with type 2 diabetes mellitus (20.8%) being the most commonly reported indication